What is the appropriate famotidine dosage for a 6‑year‑old child?

Famotidine Dosing for a 6-Year-Old Child

For a 6-year-old child with normal renal function, famotidine should be dosed at 1 mg/kg/day divided into two doses (approximately 0.5 mg/kg twice daily), not to exceed 40 mg/day total. 1

Weight-Based Dosing Approach

The appropriate famotidine dose depends critically on the child's weight:

• Children weighing less than 40 kg: Use 1 mg/kg/day divided into two doses (0.5 mg/kg twice daily), with a maximum of 40 mg/day 1
• Children weighing 40 kg or greater: May use adult tablet formulations (20 mg twice daily for GERD or erosive esophagitis) 2

Most 6-year-olds weigh less than 40 kg, so weight-based dosing at 1 mg/kg/day is the standard approach. 1

Formulation Considerations

Famotidine 20 mg and 40 mg tablets should NOT be used in children weighing less than 40 kg because these strengths exceed recommended pediatric doses. 2 For children under 40 kg, use:

• Oral suspension formulation (cherry-banana-mint flavored) 1
• Lower-dose tablet formulations if available
• Compounded preparations when commercial suspensions are unavailable

Indication-Specific Dosing

The 1 mg/kg/day divided twice daily regimen applies to:

• Peptic ulcer disease (duodenal or gastric ulcer) 1
• Symptomatic non-erosive GERD 1
• Erosive esophagitis diagnosed by endoscopy 1

Famotidine has not been established as safe or effective in pediatric patients for pathological hypersecretory conditions or duodenal ulcer recurrence prevention. 2

Pharmacokinetic Rationale

The twice-daily dosing schedule is supported by pediatric pharmacokinetic data:

• Children over 1 year demonstrate similar pharmacokinetics to adults, with an elimination half-life of approximately 3.2 hours 3
• Intravenous studies support dosing every 8-12 hours at 0.5 mg/kg per dose 4, 3
• Oral bioavailability considerations support the 1 mg/kg/day total daily dose divided twice daily 1, 4

Renal Function Adjustments

For children with impaired renal function, dose reduction is mandatory:

• Normal renal function (CrCl ≥60 mL/min): No adjustment needed 2
• Moderate impairment (CrCl 30-60 mL/min): Reduce to 0.5 mg/kg once daily or use alternate-day dosing 2
• Severe impairment (CrCl <30 mL/min): Use alternate-day dosing or further reduce frequency 2

Famotidine is substantially excreted by the kidney, making renal function assessment critical before initiating therapy. 2

Clinical Efficacy Evidence

Famotidine demonstrates superior efficacy compared to antacid therapy in pediatric peptic esophagitis:

• Symptom resolution occurred in 91.6% of children treated with famotidine versus 43.4% with alginate-antacid 5
• Mean time to symptom disappearance was 5 weeks with famotidine versus 17 weeks with antacid 5
• Histological healing of peptic esophagitis occurred in 70.8% with famotidine versus 52.2% with antacid 5

Safety Profile

Famotidine has several advantages over other H2-receptor antagonists in children:

• No cytochrome P450 interactions, unlike cimetidine 6, 4
• Longer duration of action compared to ranitidine 6
• Well-tolerated in over 150 pediatric patients studied, with no significant toxicity reported 4, 5
• CNS adverse reactions are rare but have been reported, particularly in patients with renal impairment 2

Administration Timing

Famotidine should be administered:

• Twice daily (morning and before bedtime) for most indications 2
• May be taken with or without food 2
• Can be co-administered with antacids if needed 2
• For preoperative aspiration prophylaxis, give 0.15 mg/kg at least 1.5 hours but not more than 6 hours before anesthesia 6

Common Pitfalls to Avoid

Do not use adult tablet strengths (20 mg or 40 mg) in children under 40 kg—this is the most common dosing error and can lead to overdosing. 2 Always calculate the dose based on actual body weight and use an appropriate liquid formulation or compounded preparation.

Monitor for CNS effects (confusion, agitation, hallucinations), especially in children with any degree of renal impairment, as famotidine accumulation can occur. 2

Ensure accurate measurement of liquid formulations using calibrated oral syringes or dosing devices, never household teaspoons. 7